GE HealthCare And Novo Nordisk To Collaborate To Advance Novel Non-Invasive Treatment For Type 2 Diabetes And Obesity With Ultrasound
Portfolio Pulse from Benzinga Newsdesk
GE Healthcare, a subsidiary of General Electric (GE), and Novo Nordisk have announced a collaboration to develop a non-invasive treatment for type 2 diabetes and obesity using ultrasound technology.
October 19, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
General Electric's subsidiary, GE Healthcare, is partnering with Novo Nordisk to develop a non-invasive treatment for type 2 diabetes and obesity. This could potentially open up a new market for GE.
The partnership with Novo Nordisk could potentially open up a new market for GE Healthcare, which could positively impact GE's overall revenues and profitability in the long term. However, the impact in the short term might be limited as the development and approval of the treatment could take time.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100